Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Cytological Assessment of Donor-Site Healing After Free Gingival Grafting

8. november 2026 opdateret af: Ayse Ege SELMAN, Biruni University

Cytological Evaluation of the Effects of Different Donor-Site Interventions on Healing After Free Gingival Graft Surgery

An adequate width of keratinized gingiva is important for maintaining periodontal and peri-implant tissue health. Free gingival grafting (FGG) is a commonly performed surgical procedure for increasing insufficient keratinized gingival width. This study aims to evaluate the effect of applying a chitosan sponge to the palatal donor site on wound healing after FGG using exfoliative cytology and to compare the findings with those obtained from a control group in which no chitosan sponge is applied.

At least 40 patients scheduled to undergo FGG because of insufficient keratinized gingival width will be included. The patients will be allocated to two groups: a test group and a control group. In the test group, a chitosan sponge will be applied to the palatal donor site, whereas no wound dressing will be applied to the palatal donor site in the control group. The primary outcome will be the keratinization index determined from cytological samples collected from the palatal donor site at one month after surgery. The keratinization index values at one month will be compared between the test and control groups.

All participants will receive detailed information about the study and the procedures, and written informed consent will be obtained. Clinical measurements will be recorded before surgery, after which the FGG procedure will be performed. Depending on group allocation, the palatal donor site will either be treated with a chitosan sponge or left without a wound dressing. Sutures will be removed on postoperative day 10.

For exfoliative cytological assessment, baseline samples will be collected from both the planned palatal donor site and the contralateral symmetrical healthy palatal site, which will not undergo surgery, in all patients. Samples collected from the symmetrical palatal site will serve as a reference for the baseline characteristics of healthy palatal mucosa. Follow-up samples will be collected exclusively from the palatal donor site on postoperative day 3,10 and at 1, 3, and 6 months. The keratinization index and other cellular features associated with wound healing will be assessed in the cytological samples. Findings obtained during the follow-up periods will be compared between the test group treated with a chitosan sponge and the control group in which no wound dressing is applied. In addition, the presence or absence of sensory loss at the palatal donor site will be evaluated using a periodontal probe.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

40

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 65 år (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Volunteering to participate in the study,
  • Being at least 18 years of age,
  • The need for SDG in patients with < 2 mm of keratinized gingiva on the vestibular side of the implant/tooth,
  • No prior surgical procedures or grafts in the palatal region,Volunteering to participate in the study,

Exclusion Criteria:

  • The presence of a systemic disease that would contraindicate surgical treatment,
  • Uncontrolled diabetes (HbA1c > 7),
  • Pregnancy or breastfeeding,
  • Autoimmune and/or inflammatory diseases of the oral cavity,
  • Active periodontal disease.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Behandling
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Aktiv komparator: Styring

Free gingival graft surgery

Eksperimentel: Prøve

Free gingival graft surgery

Suturing of chitosan sponge to the palatal donor site

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Palatal donor site tissue thickness:
Tidsramme: Pre-operative

The thickness of the donor site will be measured using an endodontic reamer.

Pre-operative
Palatal donor site tissue thickness:
Tidsramme: immediate Post-operative

The thickness of the donor site will be measured using an endodontic reamer.

immediate Post-operative
Palatal donor site tissue thickness:
Tidsramme: day 10

The thickness of the donor site will be measured using an endodontic reamer.

day 10
Palatal donor site tissue thickness:
Tidsramme: day 30

The thickness of the donor site will be measured using an endodontic reamer.

day 30
Palatal donor site tissue thickness:
Tidsramme: day 90

The thickness of the donor site will be measured using an endodontic reamer.

day 90
Palatal donor site tissue thickness:
Tidsramme: day 180

The thickness of the donor site will be measured using an endodontic reamer.

day 180
Keratinization Index
Tidsramme: day 3

Cells without nuclei / Total number of cells examined (n=200) × 100

day 3
Keratinization Index
Tidsramme: day 10

Cells without nuclei / Total number of cells examined (n=200) × 100

day 10
Keratinization Index
Tidsramme: day 30

Cells without nuclei / Total number of cells examined (n=200) × 100

day 30
Keratinization Index
Tidsramme: day 90

Cells without nuclei / Total number of cells examined (n=200) × 100

day 90
Keratinization Index
Tidsramme: day 180

Cells without nuclei / Total number of cells examined (n=200) × 100

day 180
Superficial cell index
Tidsramme: day 3

Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100

day 3
Superficial cell index
Tidsramme: day 10

Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100

day 10
Superficial cell index
Tidsramme: day 30

Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100

day 30
Superficial cell index
Tidsramme: day 90

Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100

day 90
Superficial cell index
Tidsramme: day 180

Total number of cells with and without pyknotic nuclei / Total number of cells examined (n=200) × 100

day 180

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Loss of sensation
Tidsramme: Day 10

To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping.

Day 10
Loss of sensation
Tidsramme: Day 30

To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping.

Day 30
Loss of sensation
Tidsramme: Day 90

To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping.

Day 90
Loss of sensation
Tidsramme: Day 180

To test it objectively, two different movements will be performed with the tip of the probe: immersion and scraping.

Day 180

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. juli 2026

Primær færdiggørelse (Anslået)

30. november 2026

Studieafslutning (Anslået)

30. december 2026

Datoer for studieregistrering

Først indsendt

8. november 2026

Først indsendt, der opfyldte QC-kriterier

8. november 2026

Først opslået (Faktiske)

16. november 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

16. november 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

8. november 2026

Sidst verificeret

1. november 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • 2015-KAEK-80-23-44

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .